Maurizio Musso

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

Robert Zeiser, Nicola Polverelli, Ron Ram et al. · New England Journal of Medicine · 2021 · 499 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

Sergio Amadori, Stefan Suciu, Dominik Selleslag et al. · Journal of Clinical Oncology · 2016 · 348 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Hematopoietic stem cell transplantation for multiple sclerosis

Jakob Passweg, A. Kazis, Tomáš Kozák et al. · Journal of Neurology · 2002 · 263 citations

Medicine, Hematology, Neurology +13

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Marco Ladetto, Federica De Marco, Fabio Benedetti et al. · Blood · 2008 · 253 citations · Full text

Medicine, Immunology, Oncology +11

Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells

Paolo Corradini, Claudia Voena, Corrado Tarella et al. · Journal of Clinical Oncology · 1999 · 242 citations

Medicine, Hematology, Oncology +16